CAG - Conagra Brands, Inc.
NYSE
->
Consumer Defensive
->
Packaged Foods
Chicago,
United States
Type: Equity
CAG price evolution
CAG
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $78.5 | $61.5 | $93.3 | $93.9 |
| Short term investments | ||||
| Net receivables | $916.5 | $974.1 | $971.5 | $965.4 |
| Inventory | $2143.4 | $2277.6 | $2393.8 | $2232 |
| Total current assets | $3285.8 | $3469.1 | $3573.5 | $3385 |
| Long term investments | ||||
| Property, plant & equipment | $2876.7 | $2876.5 | $2914.6 | $2773.8 |
| Goodwill & intangible assets | $14262 | $14274.7 | $14370.6 | $14384.1 |
| Total noncurrent assets | $18634.1 | $18650.9 | $18791.9 | $18667.6 |
| Total investments | ||||
| Total assets | $21919.9 | $22120 | $22365.4 | $22052.6 |
| Current liabilities | ||||
| Accounts payable | $1418 | $1474.6 | $1534.6 | $1529.4 |
| Deferred revenue | ||||
| Short long term debt | $1185.5 | $1576.3 | $1528.5 | $2157.4 |
| Total current liabilities | $3470.9 | $3833.1 | $3940.1 | $4440.7 |
| Long term debt | $7491.8 | $7493.3 | $7745.1 | $7081.3 |
| Total noncurrent liabilities | $9223.5 | $9212.7 | $9470.2 | $8804.6 |
| Total debt | $8677.3 | $9069.6 | $9273.6 | $9238.7 |
| Total liabilities | $12694.4 | $13045.8 | $13410.3 | $13245.3 |
| Shareholders' equity | ||||
| Retained earnings | $7011.7 | $6871.5 | $6752.9 | $6599.4 |
| Other shareholder equity | -$43.8 | -$38.7 | -$32.9 | -$44.4 |
| Total shareholder equity | $9154.9 | $9004 | $8884.5 | $8736.8 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $93.9 | $83.3 | $79.2 | $553.3 |
| Short term investments | ||||
| Net receivables | $965.4 | $867.4 | $793.9 | $860.8 |
| Inventory | $2232 | $1939.7 | $1734 | $1377.9 |
| Total current assets | $3385 | $3033.7 | $2702.1 | $2885.9 |
| Long term investments | ||||
| Property, plant & equipment | $2773.8 | $2713.9 | $2608.5 | $2389.6 |
| Goodwill & intangible assets | $14384.1 | $15182.3 | $15531.1 | $15752 |
| Total noncurrent assets | $18667.6 | $19401.4 | $19493.5 | $19418.1 |
| Total investments | ||||
| Total assets | $22052.6 | $22435.1 | $22195.6 | $22304 |
| Current liabilities | ||||
| Accounts payable | $1529.4 | $1864.6 | $1655.9 | $1525.6 |
| Deferred revenue | ||||
| Short long term debt | $2157.4 | $891.6 | $730.5 | $846.6 |
| Total current liabilities | $4440.7 | $3518.8 | $3306.2 | $3287.4 |
| Long term debt | $7081.3 | $8088.2 | $8275.2 | $8900.8 |
| Total noncurrent liabilities | $8804.6 | $10054.1 | $10258 | $11065.9 |
| Total debt | $9238.7 | $8979.8 | $9005.7 | $9747.4 |
| Total liabilities | $13245.3 | $13572.9 | $13564.2 | $14353.3 |
| Shareholders' equity | ||||
| Retained earnings | $6599.4 | $6550.7 | $6262.6 | $5471.2 |
| Other shareholder equity | -$44.4 | -$11.2 | $5.8 | -$109.6 |
| Total shareholder equity | $8736.8 | $8787.7 | $8551.8 | $7876.1 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3032.9 | $3208.1 | $2904 | $2973.3 |
| Cost of revenue | $2174.1 | $2361.5 | $2080.9 | $2189.9 |
| Gross Profit | $858.8 | $846.6 | $823.1 | $783.4 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $387.4 | $398.1 | $334.1 | $726.4 |
| Total operating expenses | $387.4 | $398.1 | $334.4 | $720.4 |
| Operating income | $471.4 | $448.5 | $488.7 | $63 |
| Income from continuing operations | ||||
| EBIT | $511 | $502.4 | $524 | $127.2 |
| Income tax expense | $95.9 | $102.9 | $98.3 | -$18.3 |
| Interest expense | $106.5 | $113.3 | $106 | $108 |
| Net income | ||||
| Net income | $308.6 | $286.2 | $319.7 | $37.5 |
| Income (for common shares) | $308.6 | $286.2 | $319.7 | $37.5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12277 | $11535.9 | $11184.7 | $11054.4 |
| Cost of revenue | $9012.2 | $8697.1 | $8005.5 | $7984.8 |
| Gross Profit | $3264.8 | $2838.8 | $3179.2 | $3069.6 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2189.5 | $1492.8 | $1403 | $1622.5 |
| Total operating expenses | $2165.3 | $1425.5 | $1348.5 | $1612.6 |
| Operating income | $1099.5 | $1413.3 | $1830.7 | $1457 |
| Income from continuing operations | ||||
| EBIT | $1311.9 | $1558.6 | $1913 | $1528.5 |
| Income tax expense | $218.7 | $290.5 | $193.8 | $201.3 |
| Interest expense | $409.6 | $379.9 | $420.4 | $487.1 |
| Net income | ||||
| Net income | $683.6 | $888.2 | $1298.8 | $840.1 |
| Income (for common shares) | $683.6 | $888.2 | $1298.8 | $840.1 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | $308.6 | $286.2 | $319.7 | $37.5 |
| Operating activities | ||||
| Depreciation | $95.8 | $99.3 | $96.6 | $92.9 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $15.2 | $6.2 | -$2.7 | $10.4 |
| Total cash flows from operations | $676.7 | $411.1 | $443.5 | $292 |
| Investing activities | ||||
| Capital expenditures | -$95.5 | -$70.1 | -$143.4 | -$94.7 |
| Investments | ||||
| Total cash flows from investing | -$91.7 | -$65.5 | -$138.4 | -$94.7 |
| Financing activities | ||||
| Dividends paid | -$167.3 | -$167.3 | -$157.4 | -$157.4 |
| Sale and purchase of stock | ||||
| Net borrowings | -$399 | -$209.5 | -$135.4 | -$20.9 |
| Total cash flows from financing | -$566.9 | -$376.3 | -$307.1 | -$177.1 |
| Effect of exchange rate | -$1.6 | $0.2 | $1.4 | $2.5 |
| Change in cash and equivalents | $17 | -$31.2 | -$0.6 | $22.7 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $683.6 | $888.2 | $1298.8 | $840.1 |
| Operating activities | ||||
| Depreciation | $369.9 | $375.4 | $387.7 | $388.9 |
| Business acquisitions & disposals | $0.1 | $160.9 | $194.6 | |
| Stock-based compensation | $79.2 | $26.1 | $63.9 | $59.2 |
| Total cash flows from operations | $995.4 | $1177.3 | $1468.1 | $1842.6 |
| Investing activities | ||||
| Capital expenditures | -$359 | -$444.2 | -$503.9 | -$355.5 |
| Investments | $5.9 | $2.7 | $7 | |
| Total cash flows from investing | -$354.9 | -$434.9 | -$340.3 | -$153.8 |
| Financing activities | ||||
| Dividends paid | -$623.8 | -$581.8 | -$474.6 | -$413.6 |
| Sale and purchase of stock | -$150 | -$50 | -$298.1 | |
| Net borrowings | $134.9 | -$75 | -$826.2 | -$947.4 |
| Total cash flows from financing | -$631.6 | -$738 | -$1609.6 | -$1370.4 |
| Effect of exchange rate | $1.7 | -$1.3 | $7.7 | -$1.7 |
| Change in cash and equivalents | $10.6 | $3.1 | -$474.1 | $316.7 |
News
Fundamentals
| Market cap | $14.95B |
|---|---|
| Enterprise value | $23.55B |
| Shares outstanding | 478.06M |
| Revenue | $12.12B |
|---|---|
| EBITDA | $2.05B |
| EBIT | $1.66B |
| Net Income | $952.00M |
| Revenue Q/Q | -1.74% |
| Revenue Y/Y | N/A |
| P/E ratio | 15.70 |
|---|---|
| EV/Sales | 1.94 |
| EV/EBITDA | 11.49 |
| EV/EBIT | 14.15 |
| P/S ratio | 1.23 |
| P/B ratio | 1.63 |
| Book/Share | 19.24 |
| Cash/Share | 0.16 |
| EPS | $1.99 |
|---|---|
| ROA | 4.30% |
| ROE | 10.64% |
| Debt/Equity | 1.52 |
|---|---|
| Net debt/EBITDA | 6.16 |
| Current ratio | 0.95 |
| Quick ratio | 0.33 |